FIELD: biochemistry; medicine.
SUBSTANCE: invention relates to a pharmaceutical composition for the treatment of convulsive syndrome. The pharmaceutical composition for the treatment of convulsive syndrome is a solution of the pharmaceutical substance of the benzodiazepine group in nicotinic acid diethylamide (nikethamide), where the pharmaceutical substance of the benzodiazepine group is selected from the group of diazepam with a concentration of 50–180 mg/ml, phenazepam with a concentration of 50–170 mg/ml, alprazolam with a concentration of 20–50 mg/ml, midazolam with a concentration of 20–50 mg/ml, triazolam with a concentration of 20–50 mg/ml, clonazepam with a concentration of 25–120 mg/ml.
EFFECT: above invention can significantly reduce the time of onset of the pharmacological effect, as well as significantly reduce side effects.
1 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC PREPARATION AT SPASMODIC SYNDROME | 2001 |
|
RU2191017C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTICONVULSANT ACTIVITY FOR PARENTERAL INTRODUCTION | 2011 |
|
RU2463052C1 |
| INITIAL ANTICONVULSANT COMPOSITIONS AND A METHOD FOR ADMINISTERING ANTICONVULSANT AGENTS | 2000 |
|
RU2264209C2 |
| COMPOSITION FOR TREATING SPASMODIC SYNDROME CASES | 2006 |
|
RU2314829C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
| AGENT FOR SERIAL CONVULSIVE SEIZURE ARRESTING | 1990 |
|
RU2080863C1 |
| MEANS FOR TREATING SPASMODIC SYNDROME CASES | 2006 |
|
RU2314828C1 |
| PREVENTIVE OR THERAPEUTIC AGENT FOR DEPRESSION OR ANXIETY DISORDER | 2006 |
|
RU2413510C2 |
| DERIVATIVE OF PYRROLIDINE ACETAMIDE OR ITS COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | 2000 |
|
RU2261093C2 |
| (1-METHYLPIPERIDIN-4-YL)-2-PROPYL PENTANOATE HYDROCHLORIDE, HAVING CHOLINOLYTIC AND ANTICONVULSANT ACTIVITY | 2019 |
|
RU2714135C1 |
